621 related articles for article (PubMed ID: 30677512)
21. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
22. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
Zhang L; Deng M; Lu A; Chen Y; Chen Y; Wu C; Tan Z; Boini KM; Yang T; Zhu Q; Wang L
J Cell Mol Med; 2019 Dec; 23(12):8139-8150. PubMed ID: 31565858
[TBL] [Abstract][Full Text] [Related]
23. SIRT1 exerts anti-hypertensive effect via FOXO1 activation in the rostral ventrolateral medulla.
Ren CZ; Wu ZT; Wang W; Tan X; Yang YH; Wang YK; Li ML; Wang WZ
Free Radic Biol Med; 2022 Aug; 188():1-13. PubMed ID: 35688305
[TBL] [Abstract][Full Text] [Related]
24. ANG II promotes IGF-IIR expression and cardiomyocyte apoptosis by inhibiting HSF1 via JNK activation and SIRT1 degradation.
Huang CY; Kuo WW; Yeh YL; Ho TJ; Lin JY; Lin DY; Chu CH; Tsai FJ; Tsai CH; Huang CY
Cell Death Differ; 2014 Aug; 21(8):1262-74. PubMed ID: 24786827
[TBL] [Abstract][Full Text] [Related]
25. Mst1 knockout enhances cardiomyocyte autophagic flux to alleviate angiotensin II-induced cardiac injury independent of angiotensin II receptors.
Cheng Z; Zhang M; Hu J; Lin J; Feng X; Wang S; Wang T; Gao E; Wang H; Sun D
J Mol Cell Cardiol; 2018 Dec; 125():117-128. PubMed ID: 30193956
[TBL] [Abstract][Full Text] [Related]
26. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
27. Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
Zhang Q; Tan Y; Zhang N; Yao F
Exp Biol Med (Maywood); 2015 Oct; 240(10):1352-61. PubMed ID: 25488910
[TBL] [Abstract][Full Text] [Related]
28. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
[TBL] [Abstract][Full Text] [Related]
29. Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Agbo E; Li MX; Wang YQ; Saahene RO; Massaro J; Tian GZ
Pharmazie; 2019 Aug; 74(8):485-491. PubMed ID: 31526442
[TBL] [Abstract][Full Text] [Related]
30. Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.
Wang S; Han HM; Pan ZW; Hang PZ; Sun LH; Jiang YN; Song HX; Du ZM; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):823-31. PubMed ID: 22569796
[TBL] [Abstract][Full Text] [Related]
31. Piperlongumine attenuates angiotensin-II-induced cardiac hypertrophy and fibrosis by inhibiting Akt-FoxO1 signalling.
Gu J; Qiu M; Lu Y; Ji Y; Qian Z; Sun W
Phytomedicine; 2021 Feb; 82():153461. PubMed ID: 33497927
[TBL] [Abstract][Full Text] [Related]
32. Ciliary neurotrophic factor overexpression protects the heart against pathological remodelling in angiotensin II-infused mice.
Zhong P; Zeng G; Lei C; Tian G; Ouyang S; Liu F; Peng J
Biochem Biophys Res Commun; 2021 Apr; 547():15-22. PubMed ID: 33588234
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
Zhang Y; Shang Z; Liu A
Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
[TBL] [Abstract][Full Text] [Related]
34. Activated FMS-like tyrosine kinase 3 ameliorates angiotensin II-induced cardiac remodelling.
Ma W; Liang F; Zhan H; Jiang X; Gao C; Zhang X; Zhang K; Sun Q; Hu H; Zhao Z
Acta Physiol (Oxf); 2020 Oct; 230(2):e13519. PubMed ID: 32480429
[TBL] [Abstract][Full Text] [Related]
35. Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1/AMPK/p70S6K signaling pathway.
Zhu J; Ning RB; Lin XY; Chai DJ; Xu CS; Xie H; Zeng JZ; Lin JX
Am J Hypertens; 2014 Aug; 27(8):1112-24. PubMed ID: 24603314
[TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.
Sun B; Huo R; Sheng Y; Li Y; Xie X; Chen C; Liu HB; Li N; Li CB; Guo WT; Zhu JX; Yang BF; Dong DL
Hypertension; 2013 Feb; 61(2):352-60. PubMed ID: 23248151
[TBL] [Abstract][Full Text] [Related]
37. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
Lyu L; Wang H; Li B; Qin Q; Qi L; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):268-79. PubMed ID: 26497614
[TBL] [Abstract][Full Text] [Related]
38. SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity.
Luo YX; Tang X; An XZ; Xie XM; Chen XF; Zhao X; Hao DL; Chen HZ; Liu DP
Eur Heart J; 2017 May; 38(18):1389-1398. PubMed ID: 27099261
[TBL] [Abstract][Full Text] [Related]
39. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
Huang CY; Lee FL; Peng SF; Lin KH; Chen RJ; Ho TJ; Tsai FJ; Padma VV; Kuo WW; Huang CY
J Cell Physiol; 2018 Feb; 233(2):979-989. PubMed ID: 28383811
[TBL] [Abstract][Full Text] [Related]
40. Sirt1 promotes autophagy and inhibits apoptosis to protect cardiomyocytes from hypoxic stress.
Luo G; Jian Z; Zhu Y; Zhu Y; Chen B; Ma R; Tang F; Xiao Y
Int J Mol Med; 2019 May; 43(5):2033-2043. PubMed ID: 30864731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
